DIURETIC EFFECT AND DIURETIC EFFICIENCY AFTER INTRAVENOUS DOSAGE OF FRUSEMIDE

被引:36
作者
ALVAN, G
HELLEDAY, L
LINDHOLM, A
SANZ, E
VILLEN, T
机构
[1] Department of Clinical Pharmacology, Karolinska Institute, Huddinge University Hospital
关键词
D O I
10.1111/j.1365-2125.1990.tb03622.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Frusemide was given intravenously at a dose of 5 mg kg‐1 to five healthy volunteers and the diuresis was assessed by frequent spontaneous voiding over 5 h. Urinary volume and contents of sodium, chloride, potassium and frusemide were measured. 2. Diuretic response was evaluated using the sigmoid Emax model and non linear regression of diuresis vs frusemide excretion rate. The time courses of diuresis (pharmacological effect) and diuretic efficiency were constructed from the fitted parameters of the sigmoid Emax model. 3. The frusemide excretion rate associated with maximum efficiency was found, as predicted theoretically, to be less than the excretion rate associated with 50% of maximum effect in four of the five subjects in whom the slope factor was less than 2. 4. The effect over time is dependent both on the instantaneous drug effect but also on its pharmacokinetic properties and mode of administration. An intravenous bolus is the least efficient mode of administration while a controlled input producing a frusemide excretion at maximum efficiency should yield up to a 2.3 times higher diuretic response. 1990 The British Pharmacological Society
引用
收藏
页码:215 / 219
页数:5
相关论文
共 10 条
[1]   INCREASED NONRENAL CLEARANCE AND INCREASED DIURETIC EFFICIENCY OF FUROSEMIDE IN CYSTIC-FIBROSIS [J].
ALVAN, G ;
BEERMANN, B ;
HJELTE, L ;
LIND, M ;
LINDHOLM, A ;
STRANDVIK, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (04) :436-441
[2]   BUMETANIDE AND FUROSEMIDE [J].
BRATER, DC ;
CHENNAVASIN, P ;
DAY, B ;
BURDETTE, A ;
ANDERSON, S .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (02) :207-213
[3]   TUBULAR CHLORIDE TRANSPORT AND MODE OF ACTION OF SOME DIURETICS [J].
BURG, MB .
KIDNEY INTERNATIONAL, 1976, 9 (02) :189-197
[4]  
HAMMARLUND MM, 1985, J PHARMACOL EXP THER, V233, P447
[5]  
Hill A. V., 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386
[6]   UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS [J].
HOLFORD, NHG ;
SHEINER, LB .
CLINICAL PHARMACOKINETICS, 1981, 6 (06) :429-453
[7]   THE TIME COURSE OF DELIVERY OF FUROSEMIDE INTO URINE - AN INDEPENDENT DETERMINANT OF OVERALL RESPONSE [J].
KAOJARERN, S ;
DAY, B ;
BRATER, DC .
KIDNEY INTERNATIONAL, 1982, 22 (01) :69-74
[8]   DETERMINATION OF FUROSEMIDE CONCENTRATIONS IN PLASMA AND URINE USING HIGH-SPEED LIQUID-CHROMATOGRAPHY [J].
LINDSTROM, B .
JOURNAL OF CHROMATOGRAPHY, 1974, 100 (01) :189-191
[9]   RENAL TUBULAR SECRETION AND EFFECTS OF FUROSEMIDE [J].
ODLIND, B ;
BEERMANN, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (06) :784-790
[10]  
1985, SAS USERS MANUAL